Lupin Q3 profit misses estimates, dips 65% on lower sales in North America, forex...

Indian drugmakers have struggled with weak sales in the United States on account of regulatory bans and warnings over quality control violations at production plants.

from Hindustan Times - business http://ift.tt/2E8mdJg